Excellence in life sciences executive search

The Chase Group Partners with Eli Lilly

December 23, 2015
Eli Lilly relies on The Chase Group once more for the recruitment of a physician to join their Breast Cancer Team. Lilly has an FDA designated breakthrough drug for breast cancer, and this physician will play a crucial role in analyzing the data from three pivotal studies and moving the compound through the global regulatory process. To learn more about The Chase Group’s strength in securing leadership talent, contact us at chase@chasegroup.com.

Chase Group

Share this Content

Copyright © 1993-2024 The Chase Group. All Rights Reserved.